DE NICOLAO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 11.111
AS - Asia 8.628
EU - Europa 7.574
SA - Sud America 928
AF - Africa 251
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 15
AN - Antartide 1
Totale 28.524
Nazione #
US - Stati Uniti d'America 10.875
CN - Cina 4.529
SG - Singapore 1.905
IE - Irlanda 1.549
UA - Ucraina 1.133
HK - Hong Kong 868
DE - Germania 795
FI - Finlandia 755
RU - Federazione Russa 713
BR - Brasile 670
VN - Vietnam 583
NL - Olanda 521
SE - Svezia 485
FR - Francia 456
GB - Regno Unito 452
IT - Italia 442
IN - India 177
ZA - Sudafrica 123
CA - Canada 121
BD - Bangladesh 84
AR - Argentina 82
IQ - Iraq 78
MX - Messico 75
BE - Belgio 52
PL - Polonia 50
TR - Turchia 48
JP - Giappone 43
EC - Ecuador 41
PK - Pakistan 41
CO - Colombia 40
MA - Marocco 34
ES - Italia 33
UZ - Uzbekistan 28
VE - Venezuela 28
ID - Indonesia 27
MY - Malesia 27
AT - Austria 26
PH - Filippine 23
PT - Portogallo 23
SA - Arabia Saudita 22
CL - Cile 21
AZ - Azerbaigian 18
JO - Giordania 18
PY - Paraguay 16
LT - Lituania 15
EU - Europa 14
TN - Tunisia 14
AU - Australia 13
IR - Iran 13
BO - Bolivia 12
DZ - Algeria 11
EG - Egitto 11
PE - Perù 11
SK - Slovacchia (Repubblica Slovacca) 11
AE - Emirati Arabi Uniti 10
NP - Nepal 10
KE - Kenya 9
KG - Kirghizistan 9
CZ - Repubblica Ceca 8
ET - Etiopia 8
TH - Thailandia 8
BH - Bahrain 7
CH - Svizzera 7
DO - Repubblica Dominicana 7
KZ - Kazakistan 7
OM - Oman 7
PA - Panama 7
BY - Bielorussia 6
GR - Grecia 6
NG - Nigeria 6
NO - Norvegia 6
SN - Senegal 6
AL - Albania 5
HN - Honduras 5
JM - Giamaica 5
KR - Corea 5
LV - Lettonia 5
LY - Libia 5
PS - Palestinian Territory 5
UY - Uruguay 5
IL - Israele 4
KW - Kuwait 4
RO - Romania 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
GA - Gabon 3
GE - Georgia 3
HU - Ungheria 3
LB - Libano 3
NI - Nicaragua 3
RS - Serbia 3
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
GT - Guatemala 2
LK - Sri Lanka 2
MU - Mauritius 2
PR - Porto Rico 2
SO - Somalia 2
SY - Repubblica araba siriana 2
Totale 28.485
Città #
Chandler 1.580
Dublin 1.548
Jacksonville 1.338
Nanjing 1.099
Singapore 993
San Jose 888
Ashburn 865
Hong Kong 833
Dallas 682
Beijing 628
Boardman 536
Nanchang 423
Princeton 327
Shenyang 306
Lawrence 296
Wilmington 289
Hebei 285
Lauterbourg 282
Changsha 265
Los Angeles 262
Jiaxing 255
Ann Arbor 236
Medford 219
Ho Chi Minh City 210
Helsinki 169
Tianjin 154
Hangzhou 151
Buffalo 150
Milan 135
Hanoi 129
Moscow 129
Woodbridge 119
Shanghai 115
Piscataway 106
Johannesburg 97
Munich 95
New York 94
Redondo Beach 88
Dearborn 81
Verona 65
São Paulo 61
Norwalk 59
Santa Clara 58
Orem 57
Seattle 53
Brussels 48
Chicago 48
Toronto 47
Frankfurt am Main 46
Pavia 46
The Dalles 45
Houston 43
Guangzhou 37
Turku 37
Warsaw 37
Des Moines 36
Tokyo 36
Kunming 34
Falkenstein 32
Montreal 32
London 30
Zhengzhou 30
Jinan 29
Mexico City 29
San Francisco 27
Brooklyn 25
Fairfield 25
Tashkent 25
Baghdad 23
Chennai 23
Da Nang 23
Dong Ket 23
Ningbo 23
Stockholm 23
Amsterdam 22
Boston 22
Manchester 22
Poplar 22
Rio de Janeiro 22
Council Bluffs 21
Denver 20
Nuremberg 20
Rome 20
Salvador 20
Atlanta 19
Mumbai 19
Washington 19
Amman 18
Hải Dương 17
Pune 17
Haiphong 16
Auburn Hills 15
Dhaka 15
Guayaquil 15
Kuala Lumpur 15
Quito 15
Taizhou 15
Baku 14
Buenos Aires 14
Changchun 14
Totale 18.240
Nome #
Steady-state equivalence of drug- and biomarker driven models in tumor growth experiments 585
Tumor-growth inhibition in preclinical animal studies: steady-state analysis of biomarker-driven models 168
First-order longitudinal population model of FEV1 data: single-trial modeling and meta-analysis 162
A Bayesian approach to non-parametric AUC estimation in population studies 161
MPC-based artificial pancreas: Strategies for individualization and meal compensation 151
A stabilizing model-based predictive control for nonlinear systems 148
Biomarker-driven models of tumor growth inhibition in preclinical animal studies 148
Artificial pancreas: Model predictive control design from clinical experience 145
A PK-PD model of tumor growth after administration of an anti-angiogenic agent given alone or in combination therapies in xenograft mice 140
A Target-Mediated Drug Disposition model integrated with a T lymphocyte pharmacodynamic model for Otelixizumab. 134
Multistep virtual metrology approaches for semiconductor manufacturing processes 133
A Bayesian nonparametric approach to AUC determination in population studies 133
Population Pharmacokinetic Model of Ibrutinib, a BTK Inhibitor for the Treatment of B-cell malignancies 132
In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time 131
A PCA approach to population analysis: with application to a Phase II depression trial 131
A Target-Mediated Drug Disposition model to quantify the relationship between Otelixizumab in vitro concentration and TCR/CD3 engagement 131
A mathematical model to study the effects of drugs administration on tumor growth dynamics 131
A Kalman filtering algorithm for regularization networks 131
Continuous-time Markov modelling of flexible-dose depression trials 130
Bayesian population approaches to the analysis of dose escalation studies 129
Multilevel Lasso Applied to Virtual Metrology in Semiconductor Manufacturing 128
PCA-based modelling in antidepressant trials: a pre-mechanistic approach 128
Methods and tools for multiscale modelling in Systems Pharmacology: a review 128
Counting events: population approaches using NONMEM 126
Adaptive Controllers for Intelligent Monitoring 126
Integration of response, tolerability and dropout in flexible-dose trials: a case study in depression 126
A Target-Mediated Drug Disposition model to quantify the relationship between Anti-CD3 monoclonal antibody and CD3/TCR receptors in Patients with autoimmune diseases. 124
A nonparametric approach for model individualization in an artificial pancreas 124
Modeling myelosuppression in patients treated with anticancer drugs 122
Multi-step virtual metrology for semiconductor manufacturing: A multilevel and regularization methods-based approach 122
Model predictive control: output feedback and tracking of nonlinear systems 121
A hidden-Gamma model-based filtering and prediction approach for monotonic health factors in manufacturing 121
Fully Integrated Artificial Pancreas in Type 1 Diabetes: Modular Closed-Loop Glucose Control Maintains Near Normoglycemia 120
A Minimal Model of Tumor Growth Inhibition in Combination Regimens under the Hypothesis of no Interaction between Drugs 119
An information-theory and Virtual Metrology-based approach to Run-to-Run semiconductor manufacturing control 119
Heart rate correction of the QT interval: a nonparametric individualized approach 118
Predicting the active doses in humans from animal studies: A novel approach in oncology 118
Process Diagnosis via Electrical-Wafer-Sorting Maps Classification 117
Second order Markov modelling of HAMD responses in depression trials 117
Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignancies 117
Some comments on nu-Support Vector Machines 116
Particle filtering of hidden Gamma processes for robust Predictive Maintenance in semiconductor manufacturing 116
Second-order indirect response modelling of complex biomarker dynamics 116
Fast calibration of two-factor models for energy option pricing 116
ACID: Automatic classification of sort test maps for interactive process diagnosis 115
Multilevel Lasso Applied to Virtual Metrology in Semiconductor Manufacturing 115
Population state-space modelling of patient responses in antidepressant studies 114
Model Predictive Control of Type 1 diabetes added to conventional therapy 114
Identification and idle speed control of internal combustion engines 114
A PK-PD model for predicting tumor growth inhibition in mice: a useful tool in oncology drug development 114
Tumor growth modelling for drug development 114
Evaluation of software tools for Bayesian estimation on population models with count and continuous data 114
Evaluation of software tools for Bayesian estimation on population models:an update based on current software versions 114
A state-space approach to disease and dropout modelling in Phase II clinical trials 113
Multilevel kernel methods for virtual metrology in semiconductor manufacturing 113
Proportional Hazard Model with L1 Penalization applied to Predictive Maintenance in Semiconductor Manufacturing 113
Testing additivity of anticancer agents in pre-clinical studies: A PK/PD modelling approach 112
A new kernel-based approach for linear system identification 112
Kernel methods in system identification, machine learning and function estimation: A survey 112
A mininal model of tumor growth inhibition 111
Temporal pharmacokinetic/pharmacodynamic interaction between human CD3ε antigen-targeted monoclonal antibody otelixizumab and CD3ε binding and expression in human peripheral blood mononuclear cell static culture 111
MPC based Artificial Pancreas: Strategies for individualization and meal compensation 111
AC/ID: a Wafer Oriented Process Diagnosis Techniques 110
A collision risk assessment approach as a basis for the on-board warning generation in cars 110
Multilevel statistical process control of asynchronous multi-stream processes in semiconductor manufacturing 110
Nonparametric identification of pharmacokinetic population models via Gaussian processes 109
Disease and dropout modelling in depression trials: a state-space approach 109
A New Neural Network Approach for Short-Term Glucose Prediction Using Continuous Glucose Monitoring Time-Series and Meal Information 109
An Algebraic Characterization of the Optimum of Regularized Kernel Methods 109
Nonparametric modelling of in vitro antitumor pharmacodynamic studies to optimize drug concentration and treatment time 108
Population modeling of tumor growth inhibition in vivo: application to anticancer drug development 108
Bayesian online multi-task learning of Gaussian processes 108
H_infinity-robustness of adaptive filters against measurement noise and parameter drift 107
A new kernel-based approach for system identification 107
A model based approach to the in vitro evaluation of anticancer activity 107
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 107
Population modeling of tumor growth in untreated xenografted mice 106
PK/PD modeling of tumor growth inhibition in vivo 106
H-infinity differential Riccati equations: convergence properties and finite escape phenomena 106
A Novel Nonparametric Approach for the Identification of the Glucose-Insulin System in Type 1 Diabetic Patients 106
Nonparametric identification of population models via Gaussian processes 105
A multi-task learning approach for the extraction of single-trial evoked potentials 105
A new statistical algorithmm to enhance volume diagnostic effectiveness and accuracy 104
Re: Antitumor Efficacy Testing in Rodents 104
Modelling of the outcome of non-inferiority trials by integration of historical data 104
Model predictive control of type 1 diabetes: An in silico trial 104
A letter on Ancaiani et al. ‘Evaluating scientific research in Italy: the 2004-10 research evaluation exercise’ 104
Nonparametric input estimation in physiological systems: Problems, methods, case studies 103
Method to evaluate the systemic exposure in toxicological and pharmacological studies 103
Dose escalation studies in Phase I clinical trials: a comparison among Bayesian population approaches 103
A minimal model describing the effect of drug administration on tumor growth dynamics 103
Multilevel Lasso Applied to Virtual Metrology in Semiconductor Manufacturing 103
Dose escalation studies: a comparison among Bayesian models 102
An EKF-based algorithm for automatic tuning and control of electrical drives 102
Day and Night Closed-Loop Control in Adults With Type 1 Diabetes: A comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management 102
Unsupervised algorithms for automatic classification of EWS maps: A comparison 101
On the zeros of discrete-time linear periodic systems 101
Modeling of human tumor xenografts and dose rationale in oncology 101
Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administrations of anticancer agents 101
Current mathematical models for cancer drug discovery 101
Totale 12.193
Categoria #
all - tutte 113.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.700


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021698 0 0 0 0 0 0 0 0 0 310 289 99
2021/20221.721 20 11 39 20 17 39 22 81 66 29 221 1.156
2022/20234.519 496 310 66 350 543 435 8 238 1.858 31 130 54
2023/20241.537 179 231 75 111 152 328 57 133 13 45 138 75
2024/20253.995 92 401 81 173 131 138 137 373 968 92 436 973
2025/20268.232 700 604 1.031 796 1.146 408 1.782 331 760 674 0 0
Totale 28.695